MedPath
HSA Approval

DEPIN-E RETARD TABLETS 20 mg

SIN11117P

DEPIN-E RETARD TABLETS 20 mg

DEPIN-E RETARD TABLETS 20 mg

September 16, 1999

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA05

nifedipine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

CADILA HEALTHCARE LTD

Active Ingredients

NIFEDIPINE

20 mg

Nifedipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.